Dentsply Sirona Inc. (XRAY)

44.18
0.77 1.71
NASDAQ : Health Technology
Prev Close 44.95
Open 45.47
Day Low/High 44.03 / 45.72
52 Wk Low/High 31.57 / 60.87
Volume 1.17M
Avg Volume 2.33M
Exchange NASDAQ
Shares Outstanding 219.08M
Market Cap 9.65B
EPS 1.20
P/E Ratio 119.08
Div & Yield 0.40 (0.88%)
The Week Ahead: Coronavirus Impact, Super Tuesday, Jobs and 30 Earnings Reports

The Week Ahead: Coronavirus Impact, Super Tuesday, Jobs and 30 Earnings Reports

Buckle up for what is likely to be another eventful five days.

Dentsply: Say 'Aaagh, Great Opportunity'

Dentsply: Say 'Aaagh, Great Opportunity'

XRAY's long-term record suggests its sharp pullback was/is still a good buying chance.

Netflix and Twitter Are Among 29 Stocks Ready to Change Direction

Netflix and Twitter Are Among 29 Stocks Ready to Change Direction

These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

Finding the stocks that have changed direction.

Women Are Still Severely Underrepresented in Corporate America

Women Are Still Severely Underrepresented in Corporate America

Women occupy just one out of five board seats at S&P 500 companies.

Jim Cramer on Why a Company's Gender Diversity Matters for Investor

Jim Cramer on Why a Company's Gender Diversity Matters for Investor

TheStreet’s Jim Cramer says investors should be a little bit more circumspect of companies that don’t promote women or have them on their boards.

Dentsply upgraded at William Blair

Here's Where to Invest When the Fed Pulls the Trigger

Consolidating industries means expanding gross margins.

Dentsply upgraded at Baird

Market Wrap: Gains Extend Far and Wide

Market Wrap: Gains Extend Far and Wide

Fed's 2-day meeting starts Wednesday.

Investing in the Retirement Crisis

Investing in the Retirement Crisis

Some companies in better position than aging population.

Dentsply downgraded at Baird

Cramer: Stocks That Stand Out

There's a powerful collection of "what's working."

Profit From the Longer Life Spans, Part 1

Profit From the Longer Life Spans, Part 1

Americans are living much longer these days -- and there are a number of ways to invest.

Dentsply downgraded at Goldman

Invest in Longevity

Invest in Longevity

Consider this unsexy but good value play in healthcare. 

Dentsply upgraded at Goldman

Dentsply upgraded at BofA/Merrill

A Dent in Dentsply

The company missed EPS expectations and guided lower. Dentsply (XRAY), a competitor to Henry Schein (HSIC), misses and guides year lower. The company sees the fiscal year's EPS at $2.33-$2.43, down from previous forecast. First-quarter earnings were...

Dentsply downgraded at UBS